|1|Grover Disease (Transient Acantholytic Dermatosis) in Acute Myeloid Leukemia on FDG PET/CT. (24152615)
Zhu H.J.... McDonald J.E.
|2|CAR T cells for acute myeloid leukemia: the LeY of the land. (24201214)
|3|Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: A report from the children's oncology group. (24285698)
Schultz K.A.... Neglia J.P.
|4|Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG. (24150216)
Fiegl M.... Hiddemann W.
|5|(6)-Gingerolinduced myeloid leukemia cell death is initiated by reactive oxygen species and activation of miR-27b expression. (24378438)
Rastogi N.... Mishra D.P.
|6|"To switch or not to switch: that is the question"-more than 10% of ratio @ 3 months: how to treat chronic myeloid leukemia patients with this response? (23806235)
Breccia M.... Alimena G.
|7|Chronic myeloid leukemia: overview of new agents and comparative analysis. (23572291)
Jain P.... Cortes J.
|8|Combinatorial molecular marker assays of WT1, survivin, and TERT at initial diagnosis of adult acute myeloid leukemia. (23826993)
Kim H.J.... Kim T.G.
|9|Preclinical and phase i results of decitabine in combination with midostaurin (PKC412) for newly diagnosed elderly or relapsed/refractory adult patients with acute myeloid leukemia. (23798029)
Williams C.B.... McGuirk J.P.
|10|Measuring the symptom burden associated with the treatment of chronic myeloid leukemia. (23777764)
Williams L.A.... Cortes J.E.
|11|BubR1 is frequently repressed in acute myeloid leukemia and its re-expression sensitizes cells to antimitotic therapy. (23812934)
Schnerch D.... WAosch R.
|12|Stem cell maintenance and disease progression in chronic myeloid leukemia. (23550022)
|13|DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia. (22124213)
Metzeler K.H.... Marcucci G.
|14|The transcription factor Wilms tumor 1 confers resistance in myeloid leukemia cells against the proapoptotic therapeutic agent TRAIL (tumor necrosis factor I+-related apoptosis-inducing ligand) by regulating the antiapoptotic protein Bcl-xL. (22898820)
Bansal H.... Bansal S.
|15|Inhibition of small GTPase RalA regulates growth and arsenic-induced apoptosis in chronic myeloid leukemia (CML) cells. (22330069)
Zhu X.... Fei J.
|16|miR-29a and miR-142-3p downregulation and diagnostic implication in human acute myeloid leukemia. (21678057)
Wang F.... Zhang J.W.
|17|Expression of four major WT1 splicing variants in acute and chronic myeloid leukemia patients analyzed by newly developed four real-time RT PCRs. (22555024)
LopotovA! T.... MoravcovA! J.
|18|Bone infarcts in a case of chronic myeloid leukemia: chronic phase. (23997459)
Sharma S.K.... Mahapatra M.
|19|Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia. (21993668)
Fried I.... WAPlfler A.
|20|Acute myeloid leukemia of donor origin after allogeneic stem cell transplantation from a sibling who harbors germline XPD and XRCC3 homozygous polymorphisms. (21951951)
Diamond H.R.... Abdelhay E.
|21|High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia. (20732714)
Lucena-Araujo A.R.... Rego E.M.
|22|Differential prognosis impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia. (21454467)
Boissel N.... Preudhomme C.
|23|Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia. (20421455)
Thol F.... Ganser A.
|24|Implementation of direct sequencing as a method of ABL gene mutations analysis in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor]. (21591355)
Florek I.... Skotnicki A.B.
|25|Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. (19797526)
Guibal F.C.... Tenen D.G.
|26|High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients. (19075190)
Tyner J.W.... Loriaux M.M.
|27|An unusual case of febrile neutropenia: acute myeloid leukemia presenting as myeloid sarcoma of the spleen. (18717148)
Chen W.L.... Tsao Y.T.
|28|Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia. (18524988)
Dulucq S.... Mahon F.X.
|29|HOX gene regulation in acute myeloid leukemia: CDX marks the spot? (17881901)
FrAPhling S.... Huntly B.J.
|30|NF-kappaB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia. (17213804)
Fabre C.... Kroemer G.
|31|Identification of novel nuclear localization signals of Drosophila myeloid leukemia factor. (18159124)
Sugano W.... Yamaguchi M.
|32|Expression of MAC-1 (CD11b) in acute myeloid leukemia (AML) is associated with an unfavorable prognosis. (16550517)
Graf M.... Schmetzer H.
|33|Clinical implications of angiogenic factors in patients with acute or chronic leukemia: hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia. (16019534)
Kim J.G.... Lee K.B.
|34|Gender aspects in chronic myeloid leukemia: long-term results from randomized studies. (15830009)
Berger U.... Hehlmann R.
|35|High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia. (15173080)
Tamm I.... Wuchter C.
|36|Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461. (15124687)
Bloomfield C.D.... Larson R.A.
|37|Acute myeloid/NK precursor cell leukemia with trisomy 4 and a novel point mutation in the extracellular domain of the G-CSF receptor in a patient with chronic idiopathic neutropenia. (15014900)
Papadaki H.A.... Eliopoulos G.D.
|38|CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations. (14726504)
FrAPhling S.... DAPhner K.
|39|Childhood and adolescent lymphoid and myeloid leukemia. (15561680)
Pui C.H.... Niemeyer C.M.
|40|Efficacy and toxicity of low-dose melphalan in myelodysplastic syndromes and acute myeloid leukemia with multilineage dysplasia. (12937849)
Robak T.... WrzesieA8-KuA9 A.
|41|Acute disseminated encephalomyelitis (ADEM) after allogeneic bone marrow transplantation for acute myeloid leukemia. (12574963)
Tomonari A.... Asano S.
|42|Mutation analysis of the origin recognition complex subunit 5 (ORC5L) gene in adult patients with myeloid leukemias exhibiting deletions of chromosome band 7q22. (11379876)
FrAPhling S.... DAPhner K.
|43|Mylotarg approved for patients with CD33+ acute myeloid leukemia. (11899326)
|44|Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factor. (10071133)
Morton J.... Taylor D.
|45|Inhibition by ascorbic acid of apoptosis induced by oxidative stress in HL-60 myeloid leukemia cells. (10075088)
Witenberg B.... Fabian I.
|46|The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias. (9234595)
Lo Coco F.... Diverio D.
|47|MTS1 expression and prognosis in acute myeloid leukemia. (9402846)
Rochlitz C.F.... Herrmann R.
|48|T-stem cell leukemia/lymphoma with both myeloid lineage conversion and T-specific delta recombination. (9379684)
Nagano M.... Kikuchi M.
|49|Production of human hematopoietic survival and growth factor by a myeloid leukemia cell line (KPB-M15) and placenta as detected by a monoclonal antibody. (3304620)
Hiraoka A.... Fukuda M.
|50|The therapeutic application of radioactive phosphorus with special reference to the treatment of primary polycythemia and chronic myeloid leukemia. (15407496)
FRIEDELL H.L.... Storaasli J.P.